Keurig Dr Pepper, US49271V1008

Resilient Keurig Dr Pepper stock holds near $31 as Q2 earnings beat and Overweight calls highlight valuation gap

Published on 08/21/2026 at 10:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Keurig Dr Pepper stock is trading close to $31 per share as of August 20, 2026, after Q2 2026 results beat expectations and fresh Overweight ratings point to upside toward the high-$30s.

Flatlay mit Aktienzertifikat, ISIN-Karte, Dosen, Flaschen und Kaffeebohnen auf Holztisch
Flatlay-Arrangement mit Aktienzertifikat, ISIN-Karte und Getränkeutensilien illustriert Investment in Keurig Dr Pepper (ISIN US49271V1008) anschaulich, Illustration mit AI erstellt.

Keurig Dr Pepper Inc. (ISIN US49271V1008) stock is trading close to $31 per share as of August 20, 2026, while recent Q2 2026 results and new Overweight ratings underline a growing valuation gap versus suggested fair value levels. Per a Q2 2026 earnings call summary dated August 20, 2026, the beverage and coffee group delivered an earnings beat and reaffirmed full-year guidance, giving investors a clearer picture of its 2026 trajectory.

Q2 2026 earnings beat with guidance reaffirmed

According to a Q2 2026 earnings call overview published on August 20, 2026, Keurig Dr Pepper reported adjusted earnings per share of $0.57 in the second quarter of 2026, ahead of consensus estimates of $0.54. That same earnings recap notes that quarterly revenue reached $7.31 billion, exceeding forecasts by $50 million and supporting the narrative of steady top-line expansion through its beverage portfolio.

The Q2 2026 report also shows legacy Keurig Dr Pepper operations delivering 7.3 percent sales growth in constant currency, while the U.S. Refreshment Beverages segment grew 10 percent, driven by brands such as Dr Pepper Zero Sugar and energy drinks. The same Q2 2026 breakdown highlights that management reaffirmed full-year 2026 revenue guidance in a range of $25.9 billion to $26.4 billion, targeting low double-digit EPS growth and a free cash flow objective of $2.5 billion, which anchors expectations for cash generation this year.

Historically, the company has emphasized its ability to balance growth and margins despite integration work in the coffee segment. In this latest Q2 2026 context, investors are watching how the integration of JDE Peet's, completed on April 1, 2026, interacts with U.S. coffee margin pressure noted in the same call summary, creating a nuanced earnings story that mixes operational progress with segment-specific challenges.

Valuation, price targets and consensus view

On the valuation side, same-day coverage dated August 20, 2026, points to Keurig Dr Pepper shares trading below a set of analyst price targets and intrinsic value estimates. One narrative cited in an August 20, 2026, valuation discussion pegs fair value at $35.65 per share, versus a prior closing price of $31.06, implying that the stock could be 12.9 percent undervalued against that fair value yardstick. The same fair value comparison frames Keurig Dr Pepper stock as still trading at a discount to modeled intrinsic value, even after recent gains.

Another detailed valuation review dated August 20, 2026, applies a GF Value metric that estimates intrinsic value for Keurig Dr Pepper at $47.01 per share, which stands 33.9 percent above a referenced price of $31.07. This GF Value-based analysis concludes that the shares look significantly undervalued on that framework and notes a dividend yield close to 3 percent, linked to the company’s cash returns policy.

At the same time, analyst coverage has been refreshed, with a research note published on August 20, 2026, highlighting an Overweight rating and a price target of $38 for Keurig Dr Pepper. This Overweight call points to discounted valuation as a key theme and argues that current pricing does not fully reflect solid growth in North America refreshment beverages. The $38 target sits well above the recent $31 handle, reinforcing the view that the market price has room to converge toward the high-$30s over time if the earnings and growth narrative holds.

Further consensus data compiled in a same-day portfolio review on August 21, 2026, cites Keurig Dr Pepper stock at $31.66, with a daily gain of 1.93 percent and a market capitalization of $42.3 billion. That market snapshot underscores that, despite the valuation gap suggested by fair value models and analyst targets, the shares remain firmly entrenched in the large-cap consumer staples universe, where defensive attributes and steady cash flow can influence investor appetite.

Trading levels and recent price action

From a trading perspective, a same-day quote overview dated August 20, 2026, reports Keurig Dr Pepper at a price of $31.64, with a prior close of $31.06 and an intraday range between $31.00 and $32.00. That intraday record also places the 52-week trading band between $24.88 on the low side and $35.59 at the high, situating the latest $31 handle in the upper half of the yearly range but still below the top.

Another same-day earnings and transcripts page shows Keurig Dr Pepper quoted at $31.66 at the regular-session close on August 20, 2026, reflecting a daily increase of 0.60 points or 1.93 percent. That quote context confirms that the stock has responded positively around the time of the Q2 2026 results, even as investors digest ongoing margin discussion in U.S. coffee and the structural split plan that will separate beverage and coffee operations.

Market commentary around the same date notes that Keurig Dr Pepper shares opened near $31.06 on August 20, 2026, on Nasdaq trading and were described as below typical analyst targets in the mid-$30s and the $38 level flagged in the Overweight call. This trading and rating summary bridges the gap between actual prices recorded in the market and the higher levels embedded in analyst and valuation frameworks, reinforcing the discount thesis.

Product example Snapple within the beverage portfolio

Within its broad beverage lineup, Keurig Dr Pepper markets Snapple as one of its key ready-to-drink brands. A company page dated August 21, 2026, highlights Snapple in the context of Keurig Dr Pepper’s portfolio, showing how the brand fits into a diverse range of flavored teas and juice drinks that support the U.S. Refreshment Beverages segment. This portfolio reference aligns with the growth reported in that segment during Q2 2026, where U.S. Refreshment Beverages registered 10 percent sales expansion, indicating that branded offerings like Snapple and Dr Pepper Zero Sugar are contributing to top-line momentum.

For investors, the product story adds texture to the headline financials. The strong performance of refreshment beverages in Q2 2026 suggests that brands positioned for flavor variety and convenience can help offset pressures elsewhere, including in coffee, where margins have been under scrutiny following integration activities. As the company advances its plan to split into dedicated beverage and coffee segments, the long-established appeal of names like Snapple may play a role in supporting valuation for the beverage-focused entity once the separation is executed.

Keurig Dr Pepper stock and market context

As of August 20, 2026, market snapshots place Keurig Dr Pepper stock near $31.64 in regular trading, within a 52-week range from $24.88 to $35.59, and backed by a market capitalization just above $42 billion. In addition, consensus data referenced in an instant alerts article dated August 21, 2026, associates Keurig Dr Pepper with a consensus rating described as Moderate Buy and a consensus price target of $34.94, pointing to incremental upside from current levels while still below the higher $38 and $47.01 fair value figures in other sources. That consensus snapshot adds another layer to the valuation view, showing that average analyst expectations sit between the live price in the low-$30s and more aggressive fair value metrics.

Across these perspectives, Keurig Dr Pepper stock currently reflects a combination of solid Q2 2026 execution, reaffirmed full-year guidance, and renewed analyst confidence, set against a market price that remains below several benchmarks. For investors focused on the beverage and coffee space within consumer staples, the stock’s positioning close to $31 while facing targets in the mid-$30s and beyond highlights how earnings delivery and strategic developments, such as the planned split, may shape whether that valuation gap narrows in the coming quarters.

Go deeper

More on Keurig Dr Pepper stock

Investor Relations

Fact box

Company: Keurig Dr Pepper Inc.

ISIN: US49271V1008

Ticker: KDP

Exchange: Nasdaq

Price (as of August 20, 2026, 4:00 p.m. ET): $31.66 USD

Market cap: $42.3 billion (as of August 21, 2026)

Sector / Industry: Consumer staples / Beverages

Index membership: S&P 500

Next earnings date: October 22, 2026

Disclaimer...

en | US49271V1008 | KEURIG DR PEPPER | boerse | 69979882 | bgmi